Page 2 - Greg Shertzer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Incyte Reports 2023 Second Quarter Financial Results and Provides Updates on Key Clinical Programs

WILMINGTON, Del. (BUSINESS WIRE) Aug 1, 2023

United statesUnited kingdomRuxolitinib jakaviBaricitinib olumiantRetifanlimab zynyzDashyant dhanakJuly incyteGreg shertzerCatalina lovemanPemigatinib pemazyreTafasitamab monjuviPonatinib iclusigCapmatinib tabrectaSyndax pharmaceuticalsTakeda pharmaceuticals internationalMillennium pharmaceuticals inc

Incyte (INCY) and Replimune (REPL) Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280

Incyte (INCY) and Replimune (REPL) Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesArleen goldenbergLance leopoldRobert coffinCatalina lovemanGreg shertzerChris brinzeySecurities exchangeExchange commissionClinical development hematologyReplimune group incGroup viceReplimune groupChief researchDevelopment officerGroup vice president

Incyte: MHRA Grants Marketing Authorisation for Opzelura (ruxolitinib) Cream for the Treatment of Non-Segmental Vitiligo with Facial Involvement in Adults and Adolescents

Incyte: MHRA Grants Marketing Authorisation for Opzelura (ruxolitinib) Cream for the Treatment of Non-Segmental Vitiligo with Facial Involvement in Adults and Adolescents
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesViktoria eleftheriadouGreg shertzerJohn dunsterLottie williamsPeter williamsCurious healthVitiligo societyIncyte announces european commission approvalHealthcare products regulatory agencyEuropean commissionExchange commissionEuropean unionJournal of the european academy dermatologyBiosciences united kingdom

MHRA Grants Marketing Authorisation for Opzelura® (ruxolitinib) Cream for the Treatment of Non-Segmental Vitiligo with Facial Involvement in Adults and Adolescents

MHRA Grants Marketing Authorisation for Opzelura® (ruxolitinib) Cream for the Treatment of Non-Segmental Vitiligo with Facial Involvement in Adults and Adolescents
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesLottie williamsJohn dunsterPeter williamsGreg shertzerViktoria eleftheriadouVitiligo societyIncyte announces european commission approvalExchange commissionEuropean commissionCurious healthHealthcare products regulatory agencyEuropean unionJournal of the european academy dermatologyBiosciences united kingdom

Data from Across Incyte s Oncology Portfolio Accepted for Presentation at the 2023 ASCO Annual Meeting and EHA2023 Hybrid Congress

Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from across its oncology portfolio will be presented at the upcoming 2023 American Society of Clinical Oncology (ASCO) Annual

United kingdomUnited statesTafasitamab monjuviGewinn nurCatalina lovemanPonatinib iclusigSteven steinGreg shertzerEuropean hematology associationLymphoma biology translational researchXencor incMacrogenics incMarrow transplant researchEuropean unionMillennium pharmaceuticals incIncyte corporation